FI893634A - Menetelmä valmistaa terapeuttisesti aktiivisia mono- tai disubstituoituja (imidatsol-4-yyli)metyylipyrido/4,3-b/indol- ja atsepino/4,3-b/indol-1-oneja - Google Patents

Menetelmä valmistaa terapeuttisesti aktiivisia mono- tai disubstituoituja (imidatsol-4-yyli)metyylipyrido/4,3-b/indol- ja atsepino/4,3-b/indol-1-oneja Download PDF

Info

Publication number
FI893634A
FI893634A FI893634A FI893634A FI893634A FI 893634 A FI893634 A FI 893634A FI 893634 A FI893634 A FI 893634A FI 893634 A FI893634 A FI 893634A FI 893634 A FI893634 A FI 893634A
Authority
FI
Finland
Prior art keywords
group
4alkyl
hydrogen atom
6alkyl
phenyl
Prior art date
Application number
FI893634A
Other languages
English (en)
Swedish (sv)
Other versions
FI92067B (fi
FI92067C (fi
FI893634A0 (fi
Inventor
Ian Harold Coates
Alexander William Oxford
Peter Charles North
Barry John Price
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888818393A external-priority patent/GB8818393D0/en
Priority claimed from GB898904195A external-priority patent/GB8904195D0/en
Priority claimed from GB898904550A external-priority patent/GB8904550D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI893634A0 publication Critical patent/FI893634A0/fi
Priority claimed from HU90608A external-priority patent/HU207078B/hu
Publication of FI893634A publication Critical patent/FI893634A/fi
Publication of FI92067B publication Critical patent/FI92067B/fi
Application granted granted Critical
Publication of FI92067C publication Critical patent/FI92067C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
FI893634A 1988-08-02 1989-08-01 Menetelmä valmistaa terapeuttisesti aktiivisia mono- tai disubstituoituja (imidatsol-4-yyli)metyylipyrido/4,3-b/indol- ja atsepino/4,3-b/indol-1-oneja FI92067C (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB888818393A GB8818393D0 (en) 1988-08-02 1988-08-02 Chemical compounds
GB8818393 1988-08-02
GB8904195 1989-02-23
GB898904195A GB8904195D0 (en) 1989-02-23 1989-02-23 Chemical compounds
GB898904550A GB8904550D0 (en) 1989-02-28 1989-02-28 Chemical compounds
GB8904550 1989-02-28
HU90608A HU207078B (en) 1988-08-02 1990-01-31 Process for producing lactam derivatives and pharmaceutical compositions comprising such compounds
HU60890 1990-01-31

Publications (4)

Publication Number Publication Date
FI893634A0 FI893634A0 (fi) 1989-08-01
FI893634A true FI893634A (fi) 1990-02-03
FI92067B FI92067B (fi) 1994-06-15
FI92067C FI92067C (fi) 1994-09-26

Family

ID=27450153

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893634A FI92067C (fi) 1988-08-02 1989-08-01 Menetelmä valmistaa terapeuttisesti aktiivisia mono- tai disubstituoituja (imidatsol-4-yyli)metyylipyrido/4,3-b/indol- ja atsepino/4,3-b/indol-1-oneja

Country Status (14)

Country Link
EP (1) EP0353983B1 (fi)
JP (1) JPH02160786A (fi)
AT (1) ATE138659T1 (fi)
AU (1) AU631131B2 (fi)
CA (1) CA1336906C (fi)
DE (1) DE68926553T2 (fi)
DK (1) DK169922B1 (fi)
ES (1) ES2088389T3 (fi)
FI (1) FI92067C (fi)
GR (1) GR3020349T3 (fi)
IL (1) IL91167A (fi)
NO (1) NO169714C (fi)
NZ (1) NZ230154A (fi)
PT (1) PT91336B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87658A (en) * 1987-09-03 1994-06-24 Glaxo Group Ltd Tetrahydro-H-) -12-imidazolylmethyl (pyrido-) and azapino- (] B) -4,3 ([indole-1-ointments, their preparation and pharmaceutical preparations containing them
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
GB8904552D0 (en) 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical process
HU204049B (en) * 1989-02-28 1991-11-28 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising same
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments
GB9011469D0 (en) * 1990-05-23 1990-07-11 Glaxo Group Ltd Chemical process
US5102889B1 (en) * 1990-09-27 1993-05-11 2-(4-piperidinyl)-1h-pyrido(4,3-b)indol-1-ones and related compounds
US5229517A (en) * 1990-09-27 1993-07-20 Hoechst-Roussel Pharmaceuticals Incorporated 2-(4-Piperindinyl)-1H-pyrido[4,3-B]indol-1-ones and related compounds
HU211081B (en) * 1990-12-18 1995-10-30 Sandoz Ag Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
EP0581388A1 (en) * 1992-07-30 1994-02-02 Glaxo Group Limited Pyridoindolone Methansulphonate as 5HT and 5HT3 receptor antagonists
GB9216154D0 (en) * 1992-07-30 1992-09-09 Glaxo Group Ltd Chemical compounds
CA2212092A1 (en) * 1995-12-01 1997-06-12 Makoto Shibata Pyrroloazepine derivatives
JP2004502642A (ja) * 2000-02-11 2004-01-29 ブリストル−マイヤーズ　スクイブ　カンパニー カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用
US6849640B2 (en) 2001-08-08 2005-02-01 Pharmacia & Upjohn Company Therapeutic 1H-pyrido [4,3-b] indoles
US6770655B2 (en) 2002-01-18 2004-08-03 Aryx Therapeutics 5-HT3 receptor antagonists and methods of use
GB0305553D0 (en) * 2003-03-11 2003-04-16 Glaxo Group Ltd Compounds
DE602006013688D1 (de) 2005-11-16 2010-05-27 Hoffmann La Roche Neues verfahren zur herstellung von thoc
RU2007139634A (ru) 2007-10-25 2009-04-27 Сергей Олегович Бачурин (RU) Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
CN102480956B (zh) 2009-04-29 2015-04-08 梅迪维新技术公司 吡啶并[4,3-b]吲哚类和使用方法
WO2010127177A1 (en) 2009-04-29 2010-11-04 Medivation Technologies, Inc. Pyrido [4,3-b] indoles and methods of use
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
SI2432467T1 (en) 2009-05-20 2018-06-29 Inserm (Institut National De La Sante Et De La Recherche Medicale) ANTAGONIST RECEPTOR SEROTONINA 5-HT3 FOR THE USE IN THE TREATMENT OF LEASE VESTIBULAR DISEASES
US8815843B2 (en) 2011-02-18 2014-08-26 Medivation Technologies, Inc. Compounds and methods of treating diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871809B (en) * 1986-11-28 1988-03-07 Glaxo Group Ltd Process for the preparation of tricyclic ketones
IL87658A (en) * 1987-09-03 1994-06-24 Glaxo Group Ltd Tetrahydro-H-) -12-imidazolylmethyl (pyrido-) and azapino- (] B) -4,3 ([indole-1-ointments, their preparation and pharmaceutical preparations containing them
HU204049B (en) * 1989-02-28 1991-11-28 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
IL91167A (en) 1993-06-10
IL91167A0 (en) 1990-03-19
FI92067B (fi) 1994-06-15
EP0353983B1 (en) 1996-05-29
AU631131B2 (en) 1992-11-19
JPH02160786A (ja) 1990-06-20
DK169922B1 (da) 1995-04-03
EP0353983A2 (en) 1990-02-07
FI92067C (fi) 1994-09-26
ATE138659T1 (de) 1996-06-15
EP0353983A3 (en) 1990-07-25
CA1336906C (en) 1995-09-05
PT91336B (pt) 1995-05-04
NO893101L (no) 1990-02-05
NZ230154A (en) 1991-10-25
GR3020349T3 (en) 1996-09-30
NO893101D0 (no) 1989-08-01
DK377889D0 (da) 1989-08-01
DE68926553D1 (de) 1996-07-04
DK377889A (da) 1990-02-03
ES2088389T3 (es) 1996-08-16
PT91336A (pt) 1990-03-08
DE68926553T2 (de) 1996-10-17
AU3918689A (en) 1990-02-08
NO169714B (no) 1992-04-21
NO169714C (no) 1992-07-29
FI893634A0 (fi) 1989-08-01

Similar Documents

Publication Publication Date Title
FI893634A (fi) Menetelmä valmistaa terapeuttisesti aktiivisia mono- tai disubstituoituja (imidatsol-4-yyli)metyylipyrido/4,3-b/indol- ja atsepino/4,3-b/indol-1-oneja
GB2209335B (en) Lactam derivatives
DE3862928D1 (de) Chinazolinon-derivate.
PE46899A1 (es) Derivados de n-fenil-sulfonamida
GB8904551D0 (en) Chemical compounds
TNSN92049A1 (fr) DERIVES D'IMIDAZO (1,2-a) (PYRROLO, THIENO OU FURANO) (3,2-d) AZEPINE, COMPOSITIONS RENFERMANT CES DERIVES ET METHODES POUR LEUR UTILISATION
ES2115608T3 (es) Procedimiento para preparar derivados lactamicos.
EP0276163A3 (en) Indole derivatives
MY102646A (en) Tricyclic ketones
MY106232A (en) Lactam derivatives
FI892415A0 (fi) Tricykliska ketoner.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: GLAXO GROUP LIMITED